Could a drug combo replace chemo and transplant for myeloma patients?
Disease control
Recruiting now
This study tests whether a combination of two drugs, elranatamab and lenalidomide, can replace high-dose chemotherapy and stem cell transplant for people newly diagnosed with multiple myeloma. About 824 participants will be randomly assigned to either standard treatment or the ex…
Phase: PHASE3 • Sponsor: Intergroupe Francophone du Myelome • Aim: Disease control
Last updated May 22, 2026 13:50 UTC